At the core of QIAGEN’s business is a vision to improve lives. We deliver on this promise by providing distinctive “Sample to Insight” solutions that help our customers unlock valuable molecular insights encoded in the building blocks of life.
QIAGEN currently has 35 subsidiaries in more than 25 countries and a global network of distribution partners in more than 60 countries. More than 6,000 employees provide expertise and service to customers in almost every corner of the world.
QIAGEN’s mission is to deliver Sample to Insight solutions enabling QIAGEN customers to unlock valuable molecular insights faster, better and more efficiently – from the raw biological sample to the final interpreted result.
BIOHT HealthCare provides products and services for the rapid diagnosis of a range of gastrointestinal diseases, as well as tests for screening and monitoring disease progression.
“We believe that innovation is the key to improvement and through our academic and clinical relationships we specialise in translating successful research applications into routine clinical use.”
BIOHIT HealthCare is a leader in gastrointestinal diagnostics and leverages the expertise of employees, consultants and partners to provide safe and cost-effective products that meet universal clinical needs.
Research and development combine expertise in different areas into integrated know-how. BIOHIT staff, along with scientific advisors representing various academic communities, apply their expertise in basic and applied research to develop innovative products for healthcare providers around the world.
Theradiag, which has been in the diagnostics market for 30 years, is now recognized as a key player in the development, production and marketing of innovative in-vitro diagnostic products, but also as a pioneer in “Theranostics”. This extensive experience in diagnostics, combined with the reliability of our products and the performance of our customer service, allows us to address biologists as a high quality partner with ISO 13 485 certification.
With a presence in more than 70 countries through in vitro diagnostic activities and benefiting from strong growth in “Theranostics”, Theradiag combines a range of unique and innovative skills to provide a personal response to each of its customers, biologists and physicians. Theradiag is a leader in “Theranostics” and in the monitoring of autoimmune diseases, which represent the third most common cause of morbidity in the world.
The German company IEM, headquartered in Aachen, has been established for more than 25 years and is one of the leading international suppliers in the premium segment.
IEM is engaged in the research, development and production of proven medical products and services. It specializes in the field of cardiovascular diseases. As a technology expert in hypertension treatment, it offers comprehensive solutions in screening, diagnosis and follow-up. Based on the results of intensive research, it develops innovative products in-house combined with a constant focus on quality, durability and user-friendliness.
Extensive research is the basis for IEM’s long-term success. To achieve this, IEM cooperates intensively with universities, research institutions and scientific leaders around the world.